LAG3 and Sepsis: Clinical observations indicate that LAG-3 expression on T cells often becomes more prominent during the later stages of sepsis, suggesting that blocking this pathway with LAG-3 antibodies may help reverse the immunosuppressive state characteristic of late sepsis, representing a potential therapeutic approach.